Medicus Pharma Ltd. (MDCX)
1.95
+0.23
(+13.37%)
USD |
NASDAQ |
Nov 13, 16:00
1.93
-0.02
(-1.03%)
After-Hours: 19:59
Medicus Pharma Enterprise Value : 14.97M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 14.97M |
| November 12, 2026 | 14.55M |
| November 11, 2026 | 14.40M |
| November 10, 2026 | 14.75M |
| November 09, 2026 | 14.85M |
| November 06, 2026 | 14.82M |
| November 05, 2026 | 14.75M |
| November 04, 2026 | 14.84M |
| November 03, 2026 | 15.12M |
| November 02, 2026 | 14.94M |
| October 30, 2026 | 14.84M |
| October 29, 2026 | 15.34M |
| October 28, 2026 | 15.95M |
| October 27, 2026 | 15.90M |
| October 26, 2026 | 16.01M |
| October 23, 2026 | 15.99M |
| October 22, 2026 | 16.21M |
| October 21, 2026 | 16.32M |
| October 20, 2026 | 16.40M |
| October 19, 2026 | 16.28M |
| October 16, 2026 | 17.38M |
| October 15, 2026 | 17.71M |
| October 14, 2026 | 17.14M |
| October 13, 2026 | 17.43M |
| October 12, 2026 | 17.99M |
| Date | Value |
|---|---|
| October 09, 2026 | 19.89M |
| October 08, 2026 | 20.79M |
| October 07, 2026 | 26.19M |
| October 06, 2026 | 26.09M |
| October 05, 2026 | 26.82M |
| October 02, 2026 | 26.26M |
| October 01, 2026 | 25.89M |
| September 30, 2026 | 26.26M |
| September 29, 2026 | 475.70M |
| September 28, 2026 | 462.16M |
| September 25, 2026 | 463.06M |
| September 24, 2026 | 482.32M |
| September 23, 2026 | 484.12M |
| September 22, 2026 | 497.96M |
| September 21, 2026 | 519.02M |
| September 18, 2026 | 516.91M |
| September 17, 2026 | 517.82M |
| September 16, 2026 | 474.49M |
| September 15, 2026 | 462.16M |
| September 14, 2026 | 483.82M |
| September 11, 2026 | 493.75M |
| September 10, 2026 | 490.14M |
| September 09, 2026 | 517.21M |
| September 08, 2026 | 516.01M |
| September 04, 2026 | 522.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals, Inc. | 1.680B |
| enGene Therapeutics, Inc. | -71.62M |
| Xenon Pharmaceuticals, Inc. | 3.033B |
| Psyence Biomedical Ltd. | -- |
| AVITA Medical, Inc. | 520.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.84M |
| Total Expenses (Quarterly) | 10.84M |
| EPS Diluted (Quarterly) | -8.315 |
| Earnings Yield | -467.7% |
| Normalized Earnings Yield | -270.83 |